Does ALS Cause Muscle Spasms and Involuntary Movements?

ALS does cause muscle spasms and involuntary movements, and these are among the earliest and most persistent symptoms of the disease. Fasciculations (visible muscle twitches beneath the skin), painful cramps, and spasticity (a constant stiffness that resists voluntary movement) all arise as motor neurons degenerate. What makes ALS distinctive is not just that these involuntary movements happen, but that they follow a recognizable trajectory and occur alongside progressive weakness, a combination that separates ALS from the many benign causes of muscle twitching.

Fasciculations Are an Early Hallmark

Fasciculations are small, involuntary contractions of a group of muscle fibers, visible as a flickering or rippling under the skin. In ALS, they are often one of the first abnormalities to appear, sometimes showing up before noticeable weakness sets in. Research describes fasciculations as “an early harbinger of dysfunction and aberrant firing of motor neurons,” arising from abnormal electrical activity generated within the motor system itself.¹ In early-stage ALS, this rogue firing likely originates higher up in the motor neuron, near the cell body. As the disease progresses and surviving neurons sprout new branches to compensate for dying neighbors, the origin of fasciculations shifts toward the ends of the nerve fibers.

The frequency of fasciculations in ALS is striking compared to ordinary benign twitching. In the biceps muscle, fasciculation rates in ALS patients were roughly ten times greater in still-strong muscles and about forty times greater in weakening muscles compared to people with benign fasciculation syndrome.² ALS fasciculations also feature “doublets,” pairs of twitches fired in rapid succession with intervals as short as five to ten milliseconds, a pattern that reflects the hyperexcitable state of damaged motor units.

The Rise and Fall Pattern

Fasciculations in ALS do not simply increase in a straight line. They follow a distinctive arc. As lower motor neurons begin to degenerate, fasciculation frequency climbs. It peaks when the affected muscle is mildly to moderately weak, then falls off as the muscle becomes severely wasted and there are simply fewer functioning motor units left to fire.³ In the biceps, researchers measured a decline in fasciculation frequency of about 7.6 twitches per minute for each month of progressive weakness.²

This rise-and-fall pattern has practical significance. A person in the early or middle stages of ALS may notice fasciculations everywhere and assume the disease is accelerating, when in fact the twitching is partly a sign that surviving motor neurons are still active and attempting to compensate. Later, the quiet that follows muscle wasting is not improvement but the result of too few motor neurons remaining to generate twitches.

Muscle Cramps and Their Severity

Beyond fasciculations, ALS frequently produces full-blown muscle cramps: sudden, painful, involuntary contractions that lock a muscle into a hard knot. In a natural-history study of people with ALS, about 78% reported cramps at their initial assessment, with an average of roughly 46 cramps per month. Most cramps lasted under a minute, but over a third of participants described the pain as moderate and nearly a quarter called it severe. A small group (about 12% of participants) experienced extremely frequent cramps, sometimes over a hundred per month.⁴

Unlike the fasciculations you can see but may not feel, cramps in ALS are a significant quality-of-life issue. They tend to strike in the calves, feet, and hands, and they can wake people from sleep repeatedly. For many patients, cramps are among the first symptoms they bring to a doctor, sometimes predating the weakness that eventually leads to diagnosis.

Spasticity and Stiffness

Spasticity is a different kind of involuntary movement problem. Where fasciculations are brief, visible twitches and cramps are sudden painful contractions, spasticity is a persistent increase in muscle tone that makes limbs feel tight, stiff, and resistant to movement. It results from damage to upper motor neurons, the cells in the brain and spinal cord that normally keep lower motor neuron activity in check. When that top-down regulation breaks down, muscles become overactive.

Spasticity commonly affects people with ALS and contributes to worsening muscle dysfunction, difficulty with daily activities, and declining quality of life.⁵ It can make walking feel like wading through wet cement, and in the arms it can interfere with tasks as basic as buttoning a shirt. Spasticity also compounds the pain burden: tight muscles pull on joints, create awkward postures, and set the stage for secondary pain that has nothing to do with the nerve damage itself.

An underappreciated wrinkle is that some of the stiffness in ALS may not be purely spastic. One study found that roughly two-thirds of ALS patients showed signs of rigidity (an extrapyramidal type of stiffness more commonly associated with Parkinson’s disease) in at least one lower-limb muscle.⁶ This suggests that ALS can affect brain circuits beyond the classic motor pathways, and that some patients’ balance and mobility problems may have components that standard anti-spasticity drugs do not fully address.

Why Motor Neurons Misfire

The fasciculations, cramps, and spasticity in ALS share a common upstream cause: motor neurons that have become electrically unstable. Research has traced this to changes in the ion channels that control how nerve cells fire. In ALS, persistent sodium channels become overactive while potassium channels, which normally act as a brake on nerve firing, are reduced.⁷ The result is a nerve cell that fires too easily and too often. Studies using motor neurons derived from ALS patients have confirmed this hyperexcitability directly, linking it to reduced potassium current in cells carrying ALS-associated genetic mutations.⁸

This hyperexcitability does double damage. It generates the involuntary movements that patients feel day to day, and it may also accelerate motor neuron death by flooding the cells with calcium.⁹ In other words, the same electrical instability that produces fasciculations and cramps may be part of the disease process that kills the neurons, not merely a side effect.

Tongue Fasciculations and Bulbar Involvement

Fasciculations are not limited to the arms and legs. When ALS affects the motor neurons that control the tongue, throat, and face (a pattern called bulbar involvement), the tongue itself can twitch visibly and continuously. Tongue fasciculations, along with difficulty speaking and swallowing, are common clinical findings in bulbar-onset ALS.¹⁰ In some cases the fasciculations are dramatic enough to extend from the tongue down to the neck muscles, making it impossible for the patient to hold the tongue out steadily.¹¹

ALS can also produce an involuntary behavior that is not a muscle spasm at all. Pseudobulbar affect is a disorder of emotional expression in which a person laughs or cries uncontrollably, out of proportion to or even disconnected from their actual feelings.¹² It stems from damage to brain circuits that regulate emotional output, and it can be deeply distressing for patients and families who mistake it for a psychiatric symptom rather than a neurological one.

When Twitching Is Not ALS

Fasciculations on their own are extremely common and usually harmless. Caffeine, stress, exercise, and poor sleep can all cause the eyelid, calf, or thumb to twitch for days or weeks. The critical distinction is what accompanies the twitching. In ALS, fasciculations co-occur with progressive weakness and wasting. In benign fasciculation syndrome, there is no weakness, no wasting, and no progression over time.

Ultrasound studies have found objective differences between ALS and benign fasciculations. In ALS, fasciculations are more frequent, higher-grade, and tend to cluster in the large muscles close to the trunk (proximal muscles of the upper and lower limbs). In non-ALS patients, fasciculations are mostly low-grade and concentrated in the smaller muscles of the hands and feet.¹³ Electrophysiology shows a similar story: ALS fasciculations fire at significantly higher rates and are more likely to occur as doublets, though the shape of the individual twitch waveform alone is not enough to tell the two apart.¹⁴

Several other conditions can mimic the twitching, cramps, and weakness profile of ALS. Cramp-fasciculation syndrome involves frequent cramps and fasciculations but no progressive weakness, and it often responds to medication.¹⁵ Kennedy disease (spinobulbar muscular atrophy), a genetic condition affecting men, produces slowly progressive lower motor neuron signs with prominent facial fasciculations and can be misdiagnosed as ALS. In one population-based study, about 13% of patients initially referred with a diagnosis of ALS turned out to have Kennedy disease instead.¹⁶

Impact on Sleep

The involuntary movements in ALS do not stop at night. Muscle cramps, spasticity, pain, and restless legs can all fragment sleep and prevent the deep rest that patients badly need.¹⁷ Reduced mobility adds another layer: when you cannot easily turn over in bed, a single cramp or spasm becomes much harder to shake off. Difficulty clearing mucus and breathing problems from weakened respiratory muscles compound the sleep disruption further.¹⁸ Poor sleep, in turn, worsens daytime fatigue, mood, and overall function, creating a cycle that is hard to break without addressing the underlying muscle symptoms.

Treatment Options for Involuntary Movements

There is no cure for ALS, but the involuntary movements it causes can be treated symptomatically, and doing so makes a real difference in daily comfort.

For cramps, the best-studied drug is mexiletine, a sodium channel blocker. A randomized crossover trial found that mexiletine reduced cramp frequency from an average of about 5.3 per day on placebo to 3.5 per day on treatment and lowered cramp severity by roughly 15 points on a 100-point scale.¹⁹ A systematic review of three randomized trials confirmed that mexiletine reliably reduces cramp frequency and severity, though it does not slow the disease itself.²⁰

Spasticity is typically managed with medications such as baclofen, tizanidine, and benzodiazepines. These can reduce stiffness, but they come with trade-offs: drowsiness, additional weakness, and fatigue are common side effects, and careful dose adjustment is needed to find the point where stiffness improves without making weakness worse.²¹ Physical therapy and stretching programs often work alongside medication to keep joints mobile and muscles as supple as possible.

A newer addition to the spasticity toolbox is nabiximols, a cannabis-based mouth spray combining THC and CBD. In a randomized placebo-controlled trial, nabiximols produced a modest but statistically significant improvement in spasticity scores with no serious adverse effects.²² Real-world follow-up data showed high patient satisfaction with the treatment.²³ This remains a relatively early-stage option, but it expands the choices available for a symptom that has long been difficult to manage well in ALS.

How Fasciculations Factor into Diagnosis

For decades, fasciculations in ALS were treated as a secondary finding during diagnosis, overshadowed by signs of active nerve-muscle disconnection seen on needle electromyography (EMG). That changed with the Awaji-shima consensus criteria, which elevated fasciculation potentials to the same diagnostic weight as fibrillation potentials and other markers of ongoing denervation.²⁴ This shift sped up diagnosis for some patients, because fasciculations can appear in muscles that have not yet developed the more advanced signs of damage.

Muscle ultrasound is emerging as a complementary tool. It is painless, quick, and can scan many muscles in a single session. Studies have found ultrasound to be more sensitive than EMG at detecting fasciculations, picking them up in muscles where the needle exam missed them.²⁵ Researchers have also used ultrasound to map the distribution of fasciculations across the body, finding that ALS patients tend to show widespread, high-grade fasciculations across multiple body regions while non-ALS patients typically show them in only one or two areas.¹³ Ultrasound is not a standalone diagnostic test for ALS, but it is increasingly used alongside EMG to build a fuller picture more quickly and with less discomfort.

Sensory Symptoms That Surprise Patients

ALS is classified as a motor neuron disease, and the textbook line is that sensation is spared. In practice, the picture is a bit messier. Some patients report tingling, numbness, and abnormal skin sensations. A study examining small nerve fibers in ALS patients found mild sensory symptoms including diffuse tingling, prickling, and decreased sensation in a subset of participants.²⁶ These sensory complaints are generally mild and not the main problem, but they can add to the confusion of early diagnosis, especially when fasciculations and cramps already have the patient anxious about what is happening to their body. Recognizing that ALS can occasionally brush against the sensory nervous system helps patients and clinicians avoid misattributing these symptoms to a separate condition.